Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind randomized phase I/IIa study of TP-102 in diabetic foot ulcers with and without infection
MOH_2021-03-26_009164Phase 2Completed
- Sponsor
- TechnoPhage
- Start
- Oct 2020
- Modality
- Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of TP-102 in diabetic foot ulcer (DFU) (4 arms), sponsored by TechnoPhage. Started Oct 2020; status: completed.
02
Drugs
TP-102
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on MOH_2021-03-26_009164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2021-03-26_009164.